Colon cancer cells treated with high doses of DNA topoisomerase I inhibitor, SN-38 [4], and ovarian cancer cells exposed to poly(ADP-ribose) polymerase inhibitor, olaparib [20], behaved similarly. The gene discussed is TOP1; the disease is ovarian carcinoma.